RESUMO
El objetivo de esta revisión fue explorar algunos antecedentes en torno de la relación salud oral y migración en tanto tópico de investigación, en el contexto nacional e internacional. Se realizó una revisión bibliográfica de textos publicados entre 2009 y 2019 en bases de datos electrónicas. Se concluyó que existen interesantes cruces posibles de hacer entre ambos ámbitos y susceptible de abordar desde diferentes técnicas y acercamientos metodológicos. No es, sin embargo, un tema suficientemente explorado dentro de los tópicos sanitarios; lo cual debiera revertirse sobretodo considerando las necesidades de informar e insumar la política pública para nuestro país.
The aim of this review is to explore some records regarding the relationship between oral health and migration as a research topic, in the national and international context. A literature review was made between 2009 and 2019 in electronic databases. It was concluded that there are interesting possible crossovers between both areas, liable to be addressed from different techniques and methodological approaches. However, this matter has not been sufficiently explored within health topics; this should be reversed, especially considering the need to inform and implement public policies in our country.
Assuntos
Humanos , Saúde Bucal , Migração Humana , Direito à SaúdeRESUMO
BACKGROUND: The optimal diagnostic and staging strategy for patients with suspected lung cancer is not known. RESEARCH QUESTION: What diagnostic and staging strategies are most cost-effective for lung cancer? STUDY DESIGN AND METHODS: A decision model was developed by using a hypothetical patient with a high probability of lung cancer. Sixteen unique permutations of bronchoscopy with fluoroscopy, radial endobronchial ultrasound, electromagnetic navigation, convex endobronchial ultrasound with or without rapid-onsite evaluation (ROSE), CT-guided biopsy (CTBx), and surgery were evaluated. Outcomes included cost, complications, mortality, time to complete the evaluation, rate of undetected N2-3 disease at surgery, incremental cost-complication ratio, and willingness-to-pay thresholds. Sensitivity analyses were performed on primary outcomes. RESULTS: For a peripheral lung lesion and radiographic N0 disease, the best bronchoscopy strategy costs $1,694 more than the best CTBx strategy but resulted in fewer complications (risk difference, 14%). The additional cost of bronchoscopy to avoid one complication from a CTBx strategy was $12,037. The cost and cumulative complications of bronchoscopy strategies increased compared with CTBx strategies for small lesions. The cost and cumulative complications of bronchoscopy strategies decreased compared with CTBx strategies when a bronchus sign was present, but bronchoscopy remained more costly overall. For a central lesion and/or radiographic N1-3 disease, convex endobronchial ultrasound with ROSE followed by lung biopsy with incremental cost-effectiveness ratio, if required, was more cost-effective than any CTBx strategy across all outcomes. Strategies with ROSE were always more cost-effective than those without, irrespective of scenario. Trade-offs also exist between different bronchoscopy strategies, and optimal choices depend on the value placed on individual outcomes and willingness-to-pay. INTERPRETATION: The most cost-effective strategies depend on nodal stage, lesion location, type of peripheral bronchoscopic biopsy, and the use of ROSE. For most clinical scenarios, many strategies can be eliminated, and trade-offs between the remaining competitive strategies can be quantified.